Related Experiment Video
Updated: Mar 24, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
[How to define treatment-resistant depression?]
Jérôme Holtzmann1, Raphaëlle Richieri2, Ghassen Saba3
1CHU de Grenoble, hôpital Nord, centre expert dépression résistante fondamental, service de psychiatrie de l'adulte, CS 10217, 38043 Grenoble cedex 9, France.
Abstract:
The most largely used definition of the treatment-resistant depression relies on the failure of two successive trials of antidepressant treatment at an adequate dose and duration. The absence of response to previous antidepressant treatments should be assessed using specific and appropriate clinical instruments enabling a correct staging of the therapeutic resistance. A wide range of socio-demographic and clinical factors (i.e. psychiatric/somatic comorbidities) are classically associated with the therapeutic resistance. The aim of the treatment of major depression is to achieve a complete clinical remission. The presence of residual symptoms increases the risk for the subsequent occurrence of relapses and recurrences, hence facilitating the development of therapeutic resistance. The treatment-resistant depression has a deleterious impact on the social, familial or professional functioning, thereby leading to an impaired quality of life with serious socioeconomic consequences and costs.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
Psychosis: Goals of Pharmacotherapy
Antidepressant Drugs: MAOIs and Other Agents
Electroconvulsive Therapy
Depression: Overview

